You just read:

Preliminary Data from the Ongoing Open-Label XmAb5871 Phase 2 Pilot Study in IgG4-Related Disease to be presented at American College of Rheumatology (ACR) 2016 Annual Meeting

News provided by

Xencor, Inc.

Oct 03, 2016, 08:00 ET